Figure GPS-7:  Lifetime prevalence and recent (last year) use of ecstasy among young adults at selected ages, 15 to 34 and 15 to 24, measured by population surveys

Notes:

Data are from the most recent national surveys available in each country (see Table GPS-2 for lifetime prevalence and Table GPS-4 for recent use among the 15–34 age group).

Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may to a small extent account for disparities between countries.

Czech Republic: 2004; 18-34 y. n=1414; 18-24 y. n=586

Denmark: 2000; 16-34 y. n=4141; 16-24 y. n=1754

Germany: 2003; 18-34 y. n=3775; 18-24 y. n=1891

Estonia: 2003; 15-34 y. n=646; 15-24 y. n=329

Greece: 2004; 15-34 y. n=2620; 15-24 y. n=1785

Spain: 2003; 15-34 y. n=5357; 15-24 y. n=2327

France: 2002; 15-34 y. n=724; 15-24 y. n=345

Ireland: 2002/03; 15-34 y. n=; 15-24 y. n=

Italy: 2003; 15-34 y. n=5231; 15-24 y. n=2112

Latvia: 2003; 15-34 y. n=; 15-24 y. n=

Lithuania: 2004; 15-34 y. n=1814; 15-24 y. n=923

Hungary: 2003; 18-34 y. n=2319; 15-24 y. n=943

Netherlands: 2000/01; 15-34 y. n=6687; 15-24 y. n= n.a.

Austria: 2004; 15-34 y. n=1754; 15-24 y. n=959

Poland: 2002; 16-34 y. n=n.a.; 16-24 y. n=n.a.

Portugal: 2001; 15-34 y. n=6406; 15-24 y. n=3099

Slovakia: 2004; 15-34 y. n=578; 15-24 y. n=307

Finland: 2004; 15-34 y. n=1031; 15-24 y. n=494

UK (E&W): 2004/05; 16-34 y. n=9913; 16-24 y. n=6287

Bulgaria: 2005; 18-34 y. n=433; 18-24 y. n=173

Romania: 2004; 15-34 y. n=; 15-24 y. n=

Norway: 2004; 15-34 y. n=1238; 15-24 y. n=645

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

Reitox national reports (2005), taken from population surveys, reports or scientific articles.

See also Table GPS-0.